InterMune (NASDAQ:ITMN)

Biotechnology word cloud

Stifel Says Strong Earnings Will Reignite Biotech Rally

When the biotech sell-off started in late February, the stocks had been market leaders for almost four years. The staggering and intense selling knocked a quick 17% off the index ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AMD, Apple, CDW, Facebook, J.C. Penney and More

Stocks are challenging new highs regularly now, but investors are nervous not to buy the top or to avoid the next major market sell off. 24/7 Wall St. looks over ...
Read Full Story »
Stock Split Image

Five Huge Sell Ratings After News: Tesla, InterMune and More

The higher the market goes, the more likely analysts are to pull the trigger on names they think are stretched. The problem for analysts: In a hot market, stocks often ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Deckers, InterMune, Medivation, Pan American Silver and More

Stocks are hitting news high, earnings season is winding down and Washington, D.C., seems to no longer be a concern. Investors still worry about buying the top and about the ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Dominated the Market on Tuesday

February 25, 2014: Markets opened slightly higher on Tuesday then bounced around the break-even line right up until the closing bell. Consumer goods, materials, and services tried to keep momentum ...
Read Full Story »
research

InterMune Lung Treatment Brings Buyout Gains, Without a Buyout

Shares of biotech company InterMune Inc. (NASDAQ: ITMN) more than doubled Tuesday after the company said its experimental drug pirfenidone, in a late-stage trial, reduced the progression of a disease ...
Read Full Story »
research

J.P. Morgan: Two Biotech Stocks to Buy With 65% to 100% Upside

Most of the major mega cap biotechnology companies have reported earnings and the results almost across the board have been very good. The problem for many investors is many of ...
Read Full Story »
Pills

Teva Acquisition Machine Gears Up: Who Is the Next Target?

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares recently hit a 52-week high after the chief financial officer of the maker of generic medicines said at a conference the company intends ...
Read Full Story »
Pills

UBS Has Nine Biotech Buyout and Merger Candidates

After three years of solid outperformance, most firms on Wall Street that we cover remain very positive on biotechnology as a whole. The analysts at UBS are not only bullish ...
Read Full Story »
biotech

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Even though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report ...
Read Full Story »

Today’s Market Winners and Losers

The stock market is down Thursday, with the Dow Jones Industrial Average down 0.23%, the Nasdaq down 0.18% and the S&P 500 down 0.16%. Today's winners include a pharmaceutical company ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ADSK, BAC, CLH, CLWR, CNQR, DVN, EXC, GMO, ITMN, JNPR, KGC, LLTC, PCS, GOLD, RIG, VALE, VE)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Thursday. Autodesk Inc. (NASDAQ: ADSK) cut to Hold at Jefferies. Bank of ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AKAM, AIG, AOL, AVGO, BKW, CMG, DV, FE, FOSL, GT, HSNI, ITMN, PCS, NRG, RA, RSH, TSO, WEC)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Tuesday morning. Akamai Technologies, Inc. (NASDAQ: AKAM) started as Outperform at William ...
Read Full Story »

24/7 Wall St. Closing Bell — July 23, 2012: Markets Fade Eurozone Continues Faltering

The three major US stock indexes opened lower this morning as Spanish 10-year bond yields rose sharply above 7% (our coverage here) and German magazine Der Spiegel published a story ...
Read Full Story »

Today’s Market Winners and Losers

The stock market is solidly down in Monday morning trading, with more fear over European debt. The Dow Jones Industrial Average is down 1.79%, the Nasdaq is down 2.34% and the S&P ...
Read Full Story »